Required fields are marked with *

Verification code

Respiratory syncytial virus (RSV) is the main causative factor of severe respiratory disease in immunodeficient populations, infants and children, with high incidence and mortality worldwide. Early and accurate diagnosis of RSV is essential for appropriate treatment.

Respiratory syncytial Virus (RSV)

CAS No. Product Name Inquiry
VV116
VV116 (JT001) is an orally active nucleoside antiviral agent against SARS-CoV-2 and respiratory syncytial virus (RSV) infection. VV116 has favorable oral bioavailability, excellent in vitro antiviral activity and selectivity.
1064-06-8
Quercetin pentaacetate
Quercetin pentaacetate interacts with RSV and inhibits the viral adhesion on cell surface.
1071517-39-9
Setrobuvir (ANA598)
Setrobuvir (ANA598) is an orally active non-nucleosidic HCV NS5B polymerase inhibitor. ANA-598 inhibits both de novo RNA synthesis and primer extension, with IC50s between 4 and 5 nM. Setrobuvir also shows excellent binding affinity to SARS- CoV-2 RdRp and induces RdRp inhibition.
1189992-00-4
Roflumilast-[d3]
A deuterated Roflumilast. Roflumilast is a selective, long-acting inhibitor of the enzyme phosphodiesterase-4 (PDE-4).
1323077-88-8
(S)-Enzaplatovir
(S)-Enzaplatovir is the S-enantiomer of Enzaplatovir. It shows antiviral activities with an EC50 of 56 nM for respiratory syncytial viral (RSV).
1323077-89-9
Enzaplatovir
Enzaplatovir (BTA-C585) is an orally bioavailable fusion inhibitor for respiratory syncytial virus (RSV) infection.
1355050-21-3
GS-443902 trisodium
GS-443902 trisodium is a potent inhibitor of viral RNA-dependent RNA-polymerases (RdRp), with IC50s of 1.1 µM, 5 µM for RSV RdRp and HCV RdRp, respectively.
1355149-45-9
GS-443902
GS-443902 is a potent inhibitor of viral RNA-dependent RNA-polymerases (RdRp), with IC50s of 1.1 µM, 5 µM for RSV RdRp and HCV RdRp, respectively.
1398065-69-4
Roflumilast-[d4]
One of the isotopic labelled form of Roflumilast, which is a selective, long-acting inhibitor of the enzyme phosphodiesterase-4 (PDE-4).
1422500-60-4
Ziresovir
Ziresovir (AK0529;RO-0529) is a potent, selective, and orally bioavailable respiratory syncytial virus (RSV) fusion (F) protein RSV F) protein inhibitor. Ziresovir shows anti-RSV activity (EC50=3 nM) and highlights pharmacokinetics in animal species.
1445379-92-9
ALS-8176 (active form)
ALS-8176 (active form), a 4'-substituted cytidine analogue, is a potent, selective RSV polymerase inhibitor. It has an EC50 of 0.15 μM in the RSV replicon assay and an IC50= 0.02 μM due to its corresponding 5'-triphosphate in the RSV polymerase assay.
1445385-02-3
Lumicitabine
Lumicitabine is an inhibitor of the respiratory syncytial virus (RSV) polymerase. It is a prodrug that converts to plasma-circulating ALS-8112, and then to the 5'-active nucleoside triphosphate (NTP) form within host cells.
1794760-31-8
Roflumilast N-oxide-[d4]
A deuterated impurity of Roflumilast. Roflumilast is a selective, long-acting inhibitor of the enzyme phosphodiesterase-4 (PDE-4).
1902114-15-1
PC786
PC786 is an inhaled respiratory syncytial virus (RSV) L protein polymerase inhibitor. It exhibits potent antiviral activity against RSV-A and RSV-B.
1903763-83-6
Sisunatovir hydrochloride
Sisunatovir is a highly potent fusion inhibitor with efficacy against a panel of clinical isolates of RSV-A and RSV-B viruses. Sisunatovir exhibited a mean IC50 of 1.2 nM against a panel of RSV A and B laboratory strains and clinical isolates with antiviral efficacy in the Balb/C mouse model of RSV infection.
1903763-82-5
Sisunatovir
Sisunatovir is a highly potent fusion inhibitor with efficacy against a panel of clinical isolates of RSV-A and RSV-B viruses. Sisunatovir exhibited a mean IC50 of 1.2 nM against a panel of RSV A and B laboratory strains and clinical isolates with antiviral efficacy in the Balb/C mouse model of RSV infection.
156722-18-8
Rostafuroxin
Rostafuroxin is a Na+/K+ ATPase modulator that treats hypertension by normalizing renal Na+/K+ ATPase pump function.
1353625-73-6
Presatovir
Presatovir is a viral fusion protein inhibitor with EC50 value of 0.43 nM. It can inhibit a broad range of respiratory syncytial virus clinical isolates by blocking the virus-cell fusion process. It can also inhibit pre- to post-fusion conformational changes of the respiratory syncytial virus fusion protein. Phase II clinical trials for the treatment of respiratory syncytial virus infections is ongoing.
1617-53-4
Amentoflavone
Amentoflavone, a natural flavonoid isolated from the the seed of Ginkgo biloba L, exhibits anti-inflammatory activity, and inhibits NF-κB/DNA binding activity potently along with inhibition of degradation of IκBα and NF-κB translocation into nucleus in TNFα-activated A549 cells. Amentoflavone has the inhibition of LPS-induced NO formation, due to its inhibition of NF-kappaB by blocking degradation, which may be the mechanistic basis of the anti-inflammatory effects of amentoflavone.
1092103-22-4
ent-11β-Hydroxyatis-16-ene-3,14-dione
ent-11β-Hydroxyatis-16-ene-3,14-dione (compound 11) is a diterpenoid from the fresh roots of Euphorbia jolkinii. ent-11β-Hydroxyatis-16-ene-3,14-dione has anti-RSV activity.

※ Please kindly note that our services are for research use only.

Copyright © 2024 BOC Sciences. All rights reserved.